Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Ferrante

Showing results (101-110 of 350) with videos related to

Pageof 35
Sort By:
Gut|February 5, 2017
Epithelial organoid cultures from patients with ulcerative colitis and Crohn's disease: a truly long-term model to study the molecular basis for inflammatory bowel disease?Manuel Noben, Bram Verstockt, Magali de Bruyn, et al.
Journal of Crohn'S & Colitis|May 14, 2013
Anxiety is associated with impaired tolerance of colonoscopy preparation in inflammatory bowel disease and controlsTalat Bessissow, Ciska-Anne Van Keerberghen, Lukas Van Oudenhove, et al.
United European Gastroenterology Journal|November 9, 2019
Outcome of biological therapies in chronic antibiotic-refractory pouchitis: A retrospective single-centre experienceBram Verstockt, Charlotte Claeys, Gert De Hertogh, et al.
Journal of Crohn'S & Colitis|November 27, 2020
Tissue Exposure does not Explain Non-Response in Ulcerative Colitis Patients with Adequate Serum Vedolizumab ConcentrationsNathalie Van den Berghe, Bram Verstockt, Ann Gils, et al.
United European Gastroenterology Journal|December 15, 2017
Human intestinal epithelium in a dish: Current models for research into gastrointestinal pathophysiologyManuel Noben, Wiebe Vanhove, Kaline Arnauts, et al.
The American Journal of Gastroenterology|August 3, 2016
A Genetic Variation in the Neonatal Fc-Receptor Affects Anti-TNF Drug Concentrations in Inflammatory Bowel DiseaseThomas Billiet, Erwin Dreesen, Isabelle Cleynen, et al.
BJS Open|January 22, 2025
Ileal pouch-anal anastomosis for ulcerative colitis: 30-year analysis on surgical evolution and patient outcomeGabriele Bislenghi, Antonio Luberto, Wout De Coster, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 11, 2020
Evaluating an easy sampling method using dried blood spots to determine vedolizumab concentrationsSumin Bian, Nathalie Van den Berghe, Liesbeth Vandersmissen, et al.
Inflammatory Bowel Diseases|August 3, 2019
A Population Pharmacokinetic and Exposure-Response Model of Golimumab for Targeting Endoscopic Remission in Patients With Ulcerative ColitisErwin Dreesen, Wannee Kantasiripitak, Iris Detrez, et al.
British Journal of Clinical Pharmacology|February 19, 2021
The effect of aging on infliximab exposure and response in patients with inflammatory bowel diseasesWannee Kantasiripitak, Bram Verstockt, Dahham Alsoud, et al.
Pageof 35

Showing results (101-110 of 350) with videos related to

Sort By:
Pageof 35
Gut|February 5, 2017
Epithelial organoid cultures from patients with ulcerative colitis and Crohn's disease: a truly long-term model to study the molecular basis for inflammatory bowel disease?Manuel Noben, Bram Verstockt, Magali de Bruyn, et al.
Journal of Crohn'S & Colitis|May 14, 2013
Anxiety is associated with impaired tolerance of colonoscopy preparation in inflammatory bowel disease and controlsTalat Bessissow, Ciska-Anne Van Keerberghen, Lukas Van Oudenhove, et al.
United European Gastroenterology Journal|November 9, 2019
Outcome of biological therapies in chronic antibiotic-refractory pouchitis: A retrospective single-centre experienceBram Verstockt, Charlotte Claeys, Gert De Hertogh, et al.
Journal of Crohn'S & Colitis|November 27, 2020
Tissue Exposure does not Explain Non-Response in Ulcerative Colitis Patients with Adequate Serum Vedolizumab ConcentrationsNathalie Van den Berghe, Bram Verstockt, Ann Gils, et al.
United European Gastroenterology Journal|December 15, 2017
Human intestinal epithelium in a dish: Current models for research into gastrointestinal pathophysiologyManuel Noben, Wiebe Vanhove, Kaline Arnauts, et al.
The American Journal of Gastroenterology|August 3, 2016
A Genetic Variation in the Neonatal Fc-Receptor Affects Anti-TNF Drug Concentrations in Inflammatory Bowel DiseaseThomas Billiet, Erwin Dreesen, Isabelle Cleynen, et al.
BJS Open|January 22, 2025
Ileal pouch-anal anastomosis for ulcerative colitis: 30-year analysis on surgical evolution and patient outcomeGabriele Bislenghi, Antonio Luberto, Wout De Coster, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 11, 2020
Evaluating an easy sampling method using dried blood spots to determine vedolizumab concentrationsSumin Bian, Nathalie Van den Berghe, Liesbeth Vandersmissen, et al.
Inflammatory Bowel Diseases|August 3, 2019
A Population Pharmacokinetic and Exposure-Response Model of Golimumab for Targeting Endoscopic Remission in Patients With Ulcerative ColitisErwin Dreesen, Wannee Kantasiripitak, Iris Detrez, et al.
British Journal of Clinical Pharmacology|February 19, 2021
The effect of aging on infliximab exposure and response in patients with inflammatory bowel diseasesWannee Kantasiripitak, Bram Verstockt, Dahham Alsoud, et al.
Pageof 35